Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (MJournal of King Saud University. Science · 2021
   Article
2. Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes.PloS one · 2021
   Article
3. Higher coronavirus disease-19 mortality linked to comorbidities: A comparison between low-middle income and high-income countries.Journal of education and health promotion · 2021
   Article
4. The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
   Article
5. Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review.New microbes and new infections · 2020
   Review
6. Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection.Frontiers in pharmacology · 2020
   Article

Corrections and comments

• Commented on by
  A sound approach: Hydroxychloroquine reduces mortality in severe COVID-19.2020
• Commented on by
  The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19.2020
• Comment on
  Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.2020

Authors and funding

5 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as